Related by context. Frequent words. (Click for all words.) 71 mRCC 71 metastatic renal cell carcinoma 70 pheochromocytoma 69 superficial bladder cancer 69 malignant pleural mesothelioma 68 chemoradiotherapy 68 cholangiocarcinoma 67 relapsed refractory multiple myeloma 67 tumor lysis syndrome 67 unresectable 66 myelodysplastic syndrome MDS 66 Natalizumab 66 lymphoma CTCL 66 chronic HCV 66 heavily pretreated 66 pleural mesothelioma 66 chlorambucil 66 Trastuzumab 66 relapsed multiple myeloma 66 Irinotecan 66 mycophenolate mofetil 66 metastatic hormone refractory 65 lupus nephritis 65 bone metastasis 65 non squamous 65 octreotide 65 chronic lymphocytic leukemia CLL 65 castration resistant prostate cancer 65 cabazitaxel 65 gastrointestinal stromal tumors 65 Carcinoma 65 indolent NHL 65 neoadjuvant chemotherapy 65 Metastatic 65 IV melanoma 64 aHUS 64 androgen deprivation 64 bleomycin 64 cystectomy 64 vandetanib 64 cytotoxic chemotherapy 64 metastatic bone 64 Erlotinib 64 Alemtuzumab 64 T#I mutation 64 FOLFIRI 64 HER2 positive metastatic breast 64 Lenalidomide 64 acute coronary syndromes ACS 64 pancreatic NET 64 secondary hyperparathyroidism 64 androgen independent 64 HSCT 64 Torisel 64 refractory multiple myeloma 64 squamous 64 systemic lupus erythematosus 64 romidepsin 64 nilotinib 64 GvHD 64 recurrent ovarian cancer 64 hepatocellular carcinoma HCC 63 neuroendocrine tumors 63 neoadjuvant therapy 63 EGFR inhibitors 63 OncoVEX GM CSF 63 breast carcinoma 63 Metastatic Melanoma 63 metastatic liver 63 pancreatic insufficiency 63 idiopathic pulmonary fibrosis IPF 63 metastatic colon cancer 63 hepatitis C HCV 63 mTOR inhibitor 63 relapsed refractory 63 painful diabetic neuropathy 63 PCa 63 nab paclitaxel 63 nasopharyngeal cancer 63 medullary thyroid cancer 63 acute myelogenous leukemia AML 63 stable angina 63 PREZISTA r 63 CMV disease 63 sunitinib 62 Zolinza 62 distant metastasis 62 Bortezomib 62 dacarbazine 62 hematological cancers 62 solid organ transplantation 62 chronic HCV infection 62 temsirolimus 62 tyrosine kinase inhibitors 62 HRPC 62 metastatic disease 62 pertuzumab 62 fluorouracil 62 neoadjuvant 62 calcineurin inhibitors 62 XELOX